These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32571819)

  • 21. Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients.
    French MA; Cerra FB; Plaut ME; Schentag JJ
    Antimicrob Agents Chemother; 1981 Jan; 19(1):147-52. PubMed ID: 7247354
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aminoglycoside nephrotoxicity: modeling, simulation, and control.
    Rougier F; Claude D; Maurin M; Sedoglavic A; Ducher M; Corvaisier S; Jelliffe R; Maire P
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1010-6. PubMed ID: 12604535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
    Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
    Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paricalcitol may improve oxidative DNA damage on experimental amikacin-induced nephrotoxicity model.
    Bulut G; Basbugan Y; Ari E; Erten R; Bektas H; Alp HH; Bayram I
    Ren Fail; 2016 Jun; 38(5):751-8. PubMed ID: 26983906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative low-dose nephrotoxicities of gentamicin, tobramycin, and amikacin.
    Hottendorf GH; Gordon LL
    Antimicrob Agents Chemother; 1980 Jul; 18(1):176-81. PubMed ID: 7416743
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does vancomycine increase aminoglycoside nephrotoxicity?
    Törel Ergür A; Onarlioglu B; Günay Y; Cetinkaya O; Eray Bulut H
    Acta Paediatr Jpn; 1997 Aug; 39(4):422-7. PubMed ID: 9316284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of renal membrane binding and nephrotoxicity of aminoglycosides.
    Williams PD; Hottendorf GH; Bennett DB
    J Pharmacol Exp Ther; 1986 Jun; 237(3):919-25. PubMed ID: 3754895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of alpha-lipoic acid on amikacin-induced nephrotoxicity.
    Asci H; Saygin M; Cankara FN; Bayram D; Yesilot S; Candan IA; Ilhan I
    Ren Fail; 2015 Feb; 37(1):117-21. PubMed ID: 25296102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of Renal Drug Exposure in Polymyxin B-Induced Nephrotoxicity.
    Manchandani P; Zhou J; Babic JT; Ledesma KR; Truong LD; Tam VH
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28096166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of higher doses of amikacin in early stages of sepsis in critically ill patients.
    Najmeddin F; Ahmadi A; Mahmoudi L; Sadeghi K; Khalili H; Ahmadvand A; Najafi A; Mojtahedzadeh M
    Acta Med Iran; 2014; 52(9):703-9. PubMed ID: 25325208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The differentiation of potential nephrotoxicity of various aminoglycosides in animal experiments].
    Sack K; Freiesleben H; Züllich B; Beck H; Schulz E
    Adv Clin Pharmacol; 1978; 15():69-90. PubMed ID: 676878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of a relationship between the serum concentration of aminoglycosides and ototoxicity in neonates.
    Setiabudy R; Suwento R; Rundjan L; Yasin FH; Louisa M; Dwijayanti A; Simanjuntak E
    Int J Clin Pharmacol Ther; 2013 May; 51(5):401-6. PubMed ID: 23557866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nephroprotective properties of taurine-amikacin treatment in rats are mediated through HSP25 and TLR-4 regulation.
    Madbouly N; Azmy A; Salama A; El-Amir A
    J Antibiot (Tokyo); 2021 Sep; 74(9):580-592. PubMed ID: 34253885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aminoglycoside nephrotoxicity: comparative assessment in critically ill patients.
    Plaut ME; Schentag JJ; Jusko WJ
    J Med; 1979; 10(4):257-66. PubMed ID: 294466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the nephrotoxicity and auditory toxicity of tobramycin and amikacin.
    Gatell JM; San Miguel JG; Zamora L; Araujo V; Bonet M; Bohé M; Jimenez de Anta MT; Farré M; Elena M; Ballesta A; Marin JL
    Antimicrob Agents Chemother; 1983 Jun; 23(6):897-901. PubMed ID: 6614894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dosing aminoglycosides once a day].
    Blaser J
    Schweiz Med Wochenschr Suppl; 1996; 76():39S-48S. PubMed ID: 8677418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin.
    Lerner SA; Schmitt BA; Seligsohn R; Matz GJ
    Am J Med; 1986 Jun; 80(6B):98-104. PubMed ID: 3524221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Habekacin: a new aminoglycoside. Study of nephrotoxicity in rats in comparison with gentamicin, netilmicin and amikacin].
    Olier B; Morin JP; Thomas N; Fillastre JP
    Pathol Biol (Paris); 1988 Jun; 36(6):795-800. PubMed ID: 3047639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity.
    Rybak MJ; Abate BJ; Kang SL; Ruffing MJ; Lerner SA; Drusano GL
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1549-55. PubMed ID: 10390201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats.
    Ozer MK; Asci H; Oncu M; Yesilot S; Savran M; Bayram D; Cicek E
    Ren Fail; 2009; 31(2):134-9. PubMed ID: 19212910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.